Literature DB >> 8683284

Prognosis for mental function in Apert's syndrome.

D Renier1, E Arnaud, G Cinalli, G Sebag, M Zerah, D Marchac.   

Abstract

The factors involved in the mental development of patients with Apert's syndrome were studied by the authors, focusing on the age of the patient at operation, associated brain malformations, and the quality of the family environment. Overall, 32% of patients with significant follow-up review had an intelligence quotient (IQ) greater than 70. Age at operation appeared to be the main factor associated with changes in mental development: final IQ was greater than 70 in 50% of patients operated on before 1 year of age versus only 7.1% in patients operated on later in life (p = 0.01). Malformations of the corpus callosum and size of the ventricles played no role in the final IQ, whereas anomalies of the septum pellucidum had a significant effect, with the proportion of patients with an IQ over 70 increasing more than twofold in patients with a normal septum compared with patients with septal anomalies (p < 0.04). Quality of the family environment was the third factor involved in intellectual achievement: only 12.5% of institutionalized children reached a normal IQ level compared to 39.3% of children from a normal family background.

Entities:  

Mesh:

Year:  1996        PMID: 8683284     DOI: 10.3171/jns.1996.85.1.0066

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  28 in total

1.  Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.

Authors:  Irene M J Mathijssen
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

2.  Callosal agenesis and Open lip Schizencephaly.

Authors:  Maya Prasad; Mary Iype; P M C Nair
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

3.  Comparison of ultrasound and magnetic resonance imaging in the prenatal diagnosis of Apert syndrome: report of a case.

Authors:  A Giancotti; V D'Ambrosio; A De Filippis; C Aliberti; G Pasquali; S Bernardo; L Manganaro
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

4.  Morphology of the foramen magnum in syndromic and non-syndromic brachycephaly: letter to the editor.

Authors:  Guillaume Coll; Federico Di Rocco
Journal:  Childs Nerv Syst       Date:  2015-04-18       Impact factor: 1.475

Review 5.  Skull vault growth in craniosynostosis.

Authors:  Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2005-03-25       Impact factor: 1.475

Review 6.  Hydrocephalus in craniosynostosis: a review.

Authors:  H Collmann; N Sörensen; J Krauss
Journal:  Childs Nerv Syst       Date:  2005-04-27       Impact factor: 1.475

Review 7.  Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling.

Authors:  Anna Kutkowska-Kaźmierczak; Monika Gos; Ewa Obersztyn
Journal:  J Appl Genet       Date:  2018-02-01       Impact factor: 3.240

Review 8.  Contemporary occurrence of hydrocephalus and Chiari I malformation in sagittal craniosynostosis. Case report and review of the literature.

Authors:  Francesco Giovanni Sgulò; Pietro Spennato; Ferdinando Aliberti; Giuliana Di Martino; Daniele Cascone; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2016-07-22       Impact factor: 1.475

9.  Focus session on the changing "epidemiology" of craniosynostosis (comparing two quinquennia: 1985-1989 and 2003-2007) and its impact on the daily clinical practice: a review from Necker Enfants Malades.

Authors:  Federico Di Rocco; Eric Arnaud; Philippe Meyer; Christian Sainte-Rose; Dominique Renier
Journal:  Childs Nerv Syst       Date:  2009-04-09       Impact factor: 1.475

Review 10.  Educational paper: parenting a child with a disfiguring condition-how (well) do parents adapt?

Authors:  Willem H Leemreis; Jolanda M E Okkerse; Peter C J de Laat; Gerard C Madern; Léon N A van Adrichem; Frank Verhulst; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2013-06-18       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.